Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model

Abstract

BACKGROUND: A possible surveillance model for patients with head and neck cancer (HNC) who received definitive radiotherapy was created using a partially observed Markov decision process. The goal of this model is to guide surveillance imaging policies after definitive radiotherapy. METHODS: The partially observed Markov decision process model was formulated to determine the optimal times to scan patients. Transition probabilities were computed using a data set of 1508 patients with HNC who received definitive radiotherapy between the years 2000 and 2010. Kernel density estimation was used to smooth the sample distributions. The reward function was derived using cost estimates from the literature. Additional model parameters were estimated using either data from the literature or clinical expertise. RESULTS: When considering all forms of relapse, the model showed that the optimal time between scans was longer than the time intervals used in the institutional guidelines. The optimal policy dictates that there should be less time between surveillance scans immediately after treatment compared with years after treatment. Comparable results also held when only locoregional relapses were considered as relapse events in the model. Simulation results for the inclusive relapse cases showed that <15% of patients experienced a relapse over a simulated 36-month surveillance program. CONCLUSIONS: This model suggests that less frequent surveillance scan policies can maintain adequate information on relapse status for patients with HNC treated with radiotherapy. This model could potentially translate into a more cost-effective surveillance program for this group of patients. Cancer 2020;126:749-756.

Accuracy of fine‐needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta‐analysis

“…In particular, current NCCN guidelines recommend ND if a positive PET/CT scan is associated with a lymph node dimension greater than 1 cm at the morphologic imaging 2 . In all cases with discordant imaging results, the decision to observe a watchful waiting or a surgical approach should be customized to the patient 16 . In this context, fine‐needle aspiration cytology (FNAC) of suspicious nodes represents a complementary tool.…”

Cost‐Effectiveness Analysis of PET‐CT Surveillance After Treatment of Human Papillomavirus‐Positive Oropharyngeal Cancer

“…This finding corroborates previous studies which suggested PET/CT surveillance's cost-effectiveness for all HNC patients without stratification by HPV status. 19,26 PET/CT, with a reported NPV of 91% to 98%, [27][28][29] with clinical surveillance has been suggested as a clinically effective approach in detecting tumor recurrence among HPV +OPSCC patients 27 ; however, no comment was made on this approach's cost-effectiveness. Our decision to perform imaging surveillance at 1 year in our model is also consistent with studies that found PET/CT's predictive ability to be optimal between 3 months and 2 years.…”

Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma

“…Our study is similar to the work by Ng et al, who developed a Markov model for HNC that was used for surveillance optimization. The same group found that imaging beyond 2 years after treatment was low yield and high cost .…”

“… 18 , 19 , 20 , 21 Markov models have already been used to simulate cancer recurrence. 22 , 23 , 24 , 25 , 26 , 27 , 28 However, many models lack disease-specific risk stratification.…”

“…They can capture the specific incidence and prognosis of local vs metastatic recurrence as well as false-positive and false-negative rates for different imaging studies . Markov models have already been used to simulate cancer recurrence . However, many models lack disease-specific risk stratification.…”